Migration of T‐cell subsets in multiple sclerosis and the effect of interferon‐β1a

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Acta Neurologica Scandinavica

• Publication date

  2007-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1600-0404.2007.00829.xPMID 17714329
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glatiramer acetate-specific human CD8(+) T cells: increased IL-4 production in multiple sclerosis is reduced by glatiramer acetate treatment.

  2006cited by this paper
• Matrix Metalloproteinase-9 and Autoimmune Diseases

  2006cited by this paper
• A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis.

  2006influential reference
• Immune surveillance in multiple sclerosis patients treated with natalizumab

  2006influential reference
• Natalizumab plus interferon beta-1a for relapsing multiple sclerosis.

  2006influential reference
• Altered CD 4 / CD 8 T-Cell Ratios in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis

  2006cited by this paper
• High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay.

  2004cited by this paper
• Interferon‐β stabilizes barrier characteristics of brain endothelial cells in vitro

  2004cited by this paper
• Interferon-beta stabilizes barrier characteristics of brain endothelial cells in vitro.

  2004cited by this paper
• Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients.

  2002cited by this paper
• Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time.

  2002cited by this paper
• Development of an ultrasensitive enzyme immunoassay for the determination of matrix metalloproteinase-9 (MMP-9) levels in normal human cerebrospinal fluid.

  2001cited by this paper
• Transmigration of PBMNCs from beta-IFN-1b-treated MS patients: a one-year longitudinal study.

  2001cited by this paper
• Clonal Expansions of Cd8+ T Cells Dominate the T Cell Infiltrate in Active Multiple Sclerosis Lesions as Shown by Micromanipulation and Single Cell Polymerase Chain Reaction

  2000cited by this paper
• Migratory behavior of lymphocytes isolated from multiple sclerosis patients: Effects of interferon β‐1b therapy

  1999cited by this paper
• Lymphocyte migration and multiple sclerosis: Relation with disease course and therapy

  1999cited by this paper
• Interferon beta in the treatment of multiple sclerosis

  1998cited by this paper
• Cytokine and chemokine regulation of proMMP-9 and TIMP-1 production by human peripheral blood lymphocytes.

  1997cited by this paper
• Autoantigen recognition by human CD8 T cell clones: enhanced agonist response induced by altered peptide ligands.

  1997cited by this paper
• Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9.

  1996cited by this paper
• Interferon beta‐1b inhibits gelatinase secretion and in vitro migration of human T cells: A possible mechanism for treatment efficacy in multiple sclerosis

  1996cited by this paper
• Interferon β‐1b decreases the migration of T lymphocytes in vitro: Effects on matrix metalloproteinase‐9

  1996cited by this paper
• [Interferon-beta in the treatment of multiple sclerosis].

  1995cited by this paper
• Autoreactive CD8+ T-cell responses to human myelin protein-derived peptides.

  1994cited by this paper
• New diagnostic criteria for multiple sclerosis: Guidelines for research protocols

  1983cited by this paper

• Application of a triple‐helical peptide inhibitor of MMP‐2/MMP‐9 to examine T‐cell activation in experimental autoimmune encephalomyelitis

  2022cites this paper
• Defective migration and dysmorphology of neutrophil granulocytes in atypical chronic myeloid leukemia treated with ruxolitinib

  2020cites this paper
• Marine n-3 polyunsaturated fatty acids: Efficacy on inflammatory-based disorders.

  2020cites this paper
• Less Neutrophil Extracellular Trap Formation in Term Newborns than in Adults

  2016cites this paper
• MS susceptibility is not affected by single nucleotide polymorphisms in the MMP9 gene.

  2015cites this paper
• Increased natural killer cell chemotaxis to CXCL12 in patients with multiple sclerosis.

  2015cites this paper
• Altered expression of the plasminogen activation pathway in peripheral blood mononuclear cells in multiple sclerosis: possible pathomechanism of matrix metalloproteinase activation

  2013cites this paper
• Missing links in multiple sclerosis etiology. A working connecting hypothesis.

  2013cites this paper
• Frequency of circulating autoreactive T cells committed to myelin determinants in relapsing-remitting multiple sclerosis patients.

  2012cites this paper
• Differential effects of interferon-ß1b on cytokine patterns of CD4+ and CD8+ T cells derived from RRMS and PPMS patients

  2012cites this paper
• Cathepsins (S and B) and their inhibitor Cystatin C in immune cells: modulation by interferon-β and role played in cell migration.

  2011cites this paper
• The Effects of Omega-3 Fatty Acids on Matrix Metalloproteinase-9 Production and Cell Migration in Human Immune Cells: Implications for Multiple Sclerosis

  2011cites this paper
• Immunological consequences of ischemic stroke: immunosuppression and autoimmunity.

  2011cites this paper
• Mitoxantrone treatment in multiple sclerosis induces TH2‐type cytokines

  2010cites this paper
• IFN-b Inhibits Dendritic Cell Migration through STAT-1–Mediated Transcriptional Suppression of CCR7 and Matrix Metalloproteinase 9

  2010cites this paper
• The current landscape and unmet needs in multiple sclerosis.

  2010cites this paper
• Results of a phase I study in patients suffering from secondary-progressive multiple sclerosis demonstrating the safety of the amino acid copolymer PI-2301 and a possible induction of an anti-inflammatory cytokine response.

  2010cites this paper
• IFN-β Inhibits Dendritic Cell Migration through STAT-1–Mediated Transcriptional Suppression of CCR7 and Matrix Metalloproteinase 9

  2010cites this paper
• Alterations in serum MMP-8, MMP-9, IL-12p40 and IL-23 in multiple sclerosis patients treated with interferon-β1b

  2010cites this paper
• Peripheral blood CD4+ T lymphocytes from multiple sclerosis patients are characterized by higher PSGL‐1 expression and transmigration capacity across a human blood‐brain barrier‐derived endothelial cell line

  2009cites this paper
• Omega-3 fatty acid supplementation decreases matrix metalloproteinase-9 production in relapsing-remitting multiple sclerosis.

  2009cites this paper
• Clinical efficacy, effects on MRI and tolerability of weekly intramuscular interferon-beta-1a in patients with MS and CIS.

  2008cites this paper